Age, Biography and Wiki
Pramod Kumar Srivastava was born on 16 August, 1955, is an An american immunologist. Discover Pramod Kumar Srivastava's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 68 years old?
| Popular As |
N/A |
| Occupation |
N/A |
| Age |
68 years old |
| Zodiac Sign |
Leo |
| Born |
16 August, 1955 |
| Birthday |
16 August |
| Birthplace |
N/A |
| Nationality |
|
We recommend you to check the complete list of Famous People born on 16 August.
He is a member of famous with the age 68 years old group.
Pramod Kumar Srivastava Height, Weight & Measurements
At 68 years old, Pramod Kumar Srivastava height not available right now. We will update Pramod Kumar Srivastava's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
Pramod Kumar Srivastava Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is Pramod Kumar Srivastava worth at the age of 68 years old? Pramod Kumar Srivastava’s income source is mostly from being a successful . He is from . We have estimated Pramod Kumar Srivastava's net worth, money, salary, income, and assets.
| Net Worth in 2024 |
$1 Million - $5 Million |
| Salary in 2024 |
Under Review |
| Net Worth in 2023 |
Pending |
| Salary in 2023 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
|
Pramod Kumar Srivastava Social Network
| Instagram |
|
| Linkedin |
|
| Twitter |
|
| Facebook |
|
| Wikipedia |
|
| Imdb |
|
Timeline
Pramod Kumar Srivastava (born 16 August 1955) is an American immunologist and physician serving as the Eversource Energy chairman in experimental oncology at the University of Connecticut School of Medicine.
He is known for his work on cancer vaccines.
He is the scientific founder of Antigenics (AGEN), the New York-based biotech company.
Srivastava completed his Ph.D. at the Centre for Cellular and Molecular Biology, Hyderabad, India, and his MD from the University of Connecticut School of Medicine.
Srivastava was appointed Assistant Professor in the Department of Pharmacology, Mount Sinai School of Medicine, in 1989.
He moved to Fordham University as an associate professor of biology in 1993 and became a full Professor in 1995.
During this time, Srivastava co-founded a biotechnology company, Antigenics, in 1994.
In 1997, he was appointed physician health services professor of medicine at the University of Connecticut School of Medicine.
He became the founding director of the Center for Immunotherapy of Cancer and Infectious Diseases.
He was also the founding chairman of the Department of Immunology.
Since 2011, he has been the director of the Carole and Neag Comprehensive Cancer Center at the University of Connecticut School of Medicine.
Srivastava made contributions to neuroimmunology.
His laboratory first identified the temperature receptors (TRPV receptors) on dendritic cells and reported the consequences of the engagement of these receptors on immune tolerance in the gut.
In addition, Srivastava investigated neuroimmunology interactions and showed how the sympathetic nervous system is critical for the normal development of neutrophils and that dysregulation of this pathway leads to the generation of the immune suppressive myeloid-derived suppressor cells, which promotes the proliferation of regulatory T cells.
Srivastava has more than 200 peer-reviewed publications and more than 200 awarded patents in the field of cancer immunology including:
